A new study revealed safe MS treatment options during pregnancy, reassuring women to balance effective care with their plans ...
Clinical trials reviewed by NICE as part of the Technology Appraisal 32 (TA32) suggested that the beta interferons and glatiramer acetate could reduce the frequency of relapses and, in some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback